Discovery of 5-substituted-6-chlorouracils as efficient inhibitors of human thymidine phosphorylase
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
17963370
DOI
10.1021/jm070644i
Knihovny.cz E-zdroje
- MeSH
- inhibitory angiogeneze chemická syntéza chemie MeSH
- kinetika MeSH
- lidé MeSH
- molekulární modely MeSH
- thymidinfosforylasa antagonisté a inhibitory MeSH
- uracil analogy a deriváty chemická syntéza chemie MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- 6-chloro-5-cyclopent-1-en-1-yluracil MeSH Prohlížeč
- inhibitory angiogeneze MeSH
- thymidinfosforylasa MeSH
- uracil MeSH
Thymidine phosphorylase plays an important role in angiogenesis, which is an attractive target for therapy of cancer and other diseases. In our continuous effort to develop novel inhibitors of thymidine phosphorylase, we have discovered that 6-halouracils substituted at position C5 by certain hydrophobic groups exhibit significant inhibitory activity against this enzyme. The most potent compounds bear a five- or six-membered cyclic substituent containing a pi-electron system at C5 and a chlorine atom attached at C6. 6-Chloro-5-cyclopent-1-en-1-yluracil 7a is the most efficient derivative in this study, with Ki = 0.20 +/- 0.03 microM (Ki/dThdKm = 0.0017) for thymidine phosphorylase expressed in V79 cells and Ki = 0.29 +/- 0.04 microM (Ki/dThdKm = 0.0024) for the enzyme purified from placenta.
Citace poskytuje Crossref.org